Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
PALO ALTO, Calif., March 6 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) invites investors, media and the public to a live webcast of the company's 2008 investor meeting. The corporate presentation will begin at 10:00 a.m. Eastern Time/7:00 a.m. Pacific Time on Thursday, March 13, 2008. The meeting is expected to last approximately two hours.
Members of Jazz Pharmaceuticals' senior management team will provide a comprehensive overview of commercial and product development activities and a financial update, including:
- a review of LUVOX(R) CR product launch activities;
- an in-depth discussion of product candidates in development; and
- 2008 financial guidance.
The live webcast may be accessed on Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the meeting to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through March 27, 2008.
About Jazz Pharmaceuticals, Inc. Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit http://www.JazzPharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.
CONTACT:
Jim Karrels, Executive Director, Finance, of Jazz Pharmaceuticals, Inc., +1-650-496-2800,
investorinfo@jazzpharma.com;
or
Karen L. Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both
of BCC Partners, for Jazz Pharmaceuticals, Inc.
Web site: http://www.jazzpharmaceuticals.com